Mawdsleys announces new solus deal with M&A Pharmachem
Mawdsleys announces new solus deal with M&A Pharmachem 9th June 2014

Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.

 

From 1st July 2014, Mawdsleys  will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly.   As from this date, all orders for M&A products will need to be purchased via Mawdsleys.

 

The full range of M&A products will available through Mawdsleys, and customers will be able to;

 

Benefit from EDI or online ordering

 View invoices online

View contract prices online

View M&A stock availability online

Benefit from no minimum order levels

Purchase M&A products over labelled where required

Benefit from daily deliveries from your local depot

 

Stock will be available from 1st July 2014, and you can order your M&A Pharmachem products from Mawdsleys through your normal preferred route; i.e. fax, EDI, through the Mawdsleys online ordering system – E-Awards, or by calling your local depot.

 

Should you have any queries, please feel free to contact your local Mawdsleys Account Manager.

 

You may also contact Mawdsleys customer service on 0844 736 9016 or info@mawdsleys.co.uk

 

Your M&A contact is Beverley Byrne on 01942 816184

Other latest news
https://www.mawdsleys.co.uk/news/tillomed-laboratories-choose-mawdsleys-as-their-distributor-to-hospitals/ thumbnail image Tillomed Laboratories choose Mawdsleys as their distributor to hospitals

Mawdsleys are delighted to be assisting Tillomed Laboratories in bringing their injectable products to market (September 2017). We will be distributing CMU contracted products to English hospitals and products with special prices to Scotland, Wales and Northern Ireland:     Description: Carmustine Injection Vial 100mg Pack: 100mg PIP Code: 7936438 EAN Code: 008902319061371 Description: Cidofovir…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-sources-compassionate-access-for-critically-ill-patient/ thumbnail image Mawdsleys secures compassionate access for critically ill patient

  We are extremely proud of our patient-centric unrivalled service at Mawdsleys.   Over a recent bank holiday, our unlicensed team received an urgent, time-sensitive order request from a leading NHS children’s hospital in the North West to secure compassionate access to a medicine on clinical trial in North America…

Read more
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.